
The authors have reviewed applications of novel technologies in the major stages of biosimilars development: process development, pharmacology, toxicology, and clinical trials, with an emphasis on recent regulatory requirements.
Smritie Sheth is scientific manager at SymphonyTech Biologics.
The authors have reviewed applications of novel technologies in the major stages of biosimilars development: process development, pharmacology, toxicology, and clinical trials, with an emphasis on recent regulatory requirements.
A task force details its findings of the risks associated with using convalescent plasma using failure mode and effects analysis
Amid the rush for a SARS-CoV-2 vaccine to deal with the COVID-19 pandemic, a robust risk assessment must be conducted, and mitigation strategies applied.
Published: August 7th 2024 | Updated:
Published: February 3rd 2021 | Updated: